A new CAR T-cell therapy designed to treat gastric (stomach) and pancreatic cancers will soon be available to patients in…
Articles by Marisa Wexler, MS
The U.S. Food and Drug Administration (FDA) has awarded orphan drug designation to the experimental radiation therapy rhenium Re186 obisbemeda…
A test that uses artificial intelligence (AI) to analyze genetic data from a vaginal swab can detect endometrial cancer with…
Caris Life Sciences has developed a genetic test that aims to simplify care for people with a group of…
A type of electrical therapy called Tumor Treating Fields (TTFields), given in combination with chemotherapy and other medication, may help…
The U.S. Food and Drug Administration (FDA) has granted fast-track designation to the experimental therapy ZW191 as a potential treatment…
A European Medicines Agency (EMA) panel has recommended approval of a subcutaneous (under-the-skin) version of Sarclisa (isatuximab), an approved…
Adding Amplia Therapeutics‘ experimental drug narmafotinib to standard chemotherapy led to complete responses — meaning no detectable cancer on…
Most doctors who treat multiple myeloma expect that CAR T-cell therapies will soon became the standard first-line treatment,…
Tempus AI, a technology company focused on advancing precision medicine using artificial intelligence (AI), has announced a strategic collaboration…